ICMR disbands committee formed on research for drug and vaccine

MUMBAI: The Indian Council of Medical Research (ICMR) has disbanded a committee tasked with research for developing a vaccine and drugs to deal with the Covid-19 pandemic, a member of the panel said. No reason was given for the decision by country’s top health body.

The panel was constituted on April 6 and had looked at 100 vaccine candidates and was in the process of identifying new areas of drug and vaccine development.
Debashis Mitra of the National Centre for Cell Science, who was one of the nine members on the committee said, “We got a mail from the chairman (of ICMR) in this regard a few days ago. The panel had met three times in a span of 10 days. However, after the third meeting, the committee was dissolved; we were told that the Department of Biotechnology (DBT) will now look into this.”

The ICMR had formed a task force with five groups on April 6, . These were in the areas of clinical research, research on diagnostics and bio-markers, epidemiology and surveillance, operations research and vaccines/drug research and development. In February, the DBT had formed a group to look at drugs and vaccines research for Covid-19 and had called for proposals from companies.

  • Related Posts

    • Health
    • February 10, 2024
    • 26 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Millets reigned Supreme in International Symposium on Gut Health

    New Delhi: Millets reign supreme as gut health assumes most important aspect of the latest preventive and curative healthcare approach. This fact was writ large on Symposium on ‘Gut Health…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Significant Decline In Pharma Deals In Q1

    Significant Decline In Pharma Deals In Q1

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    Glenmark recalls 6,528 bottles of BP drug in US

    Glenmark recalls 6,528 bottles of BP drug in US

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    CAHO Naa Patients Se Pyaar Hai

    CAHO Naa Patients Se Pyaar Hai